ATE237316T1 - Ibuprofen und domperidone enthaltende pharmazeutische zusammensetzungen - Google Patents
Ibuprofen und domperidone enthaltende pharmazeutische zusammensetzungenInfo
- Publication number
- ATE237316T1 ATE237316T1 AT99948741T AT99948741T ATE237316T1 AT E237316 T1 ATE237316 T1 AT E237316T1 AT 99948741 T AT99948741 T AT 99948741T AT 99948741 T AT99948741 T AT 99948741T AT E237316 T1 ATE237316 T1 AT E237316T1
- Authority
- AT
- Austria
- Prior art keywords
- domperidone
- pharmaceutical compositions
- compositions containing
- containing ibuprofen
- carrier material
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9816899.0A GB9816899D0 (en) | 1998-08-05 | 1998-08-05 | Therapeutic agents |
PCT/EP1999/005753 WO2000007570A1 (en) | 1998-08-05 | 1999-08-04 | Pharmaceutical compositions comprising ibuprofen and domperidone |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE237316T1 true ATE237316T1 (de) | 2003-05-15 |
Family
ID=10836640
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99948741T ATE237316T1 (de) | 1998-08-05 | 1999-08-04 | Ibuprofen und domperidone enthaltende pharmazeutische zusammensetzungen |
Country Status (23)
Country | Link |
---|---|
US (2) | US6991806B1 (de) |
EP (1) | EP1100472B1 (de) |
JP (1) | JP2002522377A (de) |
KR (1) | KR20010072269A (de) |
CN (1) | CN1321084A (de) |
AT (1) | ATE237316T1 (de) |
AU (1) | AU755835B2 (de) |
BG (1) | BG105303A (de) |
BR (1) | BR9912706A (de) |
CA (1) | CA2339193C (de) |
DE (1) | DE69906982T2 (de) |
ES (1) | ES2197676T3 (de) |
GB (1) | GB9816899D0 (de) |
HU (1) | HUP0103421A3 (de) |
IL (1) | IL141055A0 (de) |
MX (1) | MXPA01001120A (de) |
NO (1) | NO20010537L (de) |
NZ (1) | NZ509806A (de) |
PL (1) | PL345811A1 (de) |
SK (1) | SK1752001A3 (de) |
TR (1) | TR200100611T2 (de) |
WO (1) | WO2000007570A1 (de) |
ZA (1) | ZA200100936B (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9816899D0 (en) * | 1998-08-05 | 1998-09-30 | Boots Co Plc | Therapeutic agents |
US6673369B2 (en) | 2001-08-29 | 2004-01-06 | Ranbaxy Laboratories Limited | Controlled release formulation |
JP4427453B2 (ja) * | 2002-12-20 | 2010-03-10 | エフ.ホフマン−ラ ロシュ アーゲー | 高用量イバンドロネート製剤 |
BRPI0413394A8 (pt) * | 2003-08-26 | 2016-03-08 | Shire Holdings Ag | Formulação de lantânio mastigável em tablete, formulação farmacêutica em tablete ou em pó, método para tratar hiperfosfatemia, uso de uma quantidade terapeuticamente efetiva de uma formulação de um composto de lantânio, processo para preparar uma formulação em tablete de um composto de lantânio |
JP4575654B2 (ja) * | 2003-09-05 | 2010-11-04 | エスエス製薬株式会社 | 溶解性と流動性を改善した医薬組成物 |
US20050065172A1 (en) * | 2003-09-23 | 2005-03-24 | Shah Indukumar G. | Solid dosage form comprising caffeine |
ES2244324B1 (es) * | 2004-03-25 | 2006-11-16 | Ferrer Internacional, S.A. | Composiciones diureticas de liberacion prolongada. |
JP3996626B2 (ja) * | 2004-06-22 | 2007-10-24 | 塩野義製薬株式会社 | 口腔内速崩壊錠 |
US20060068009A1 (en) * | 2004-09-30 | 2006-03-30 | Scolr Pharma, Inc. | Modified release ibuprofen dosage form |
US20070077297A1 (en) | 2004-09-30 | 2007-04-05 | Scolr Pharma, Inc. | Modified release ibuprofen dosage form |
EP1905428A1 (de) * | 2006-09-26 | 2008-04-02 | Losan Pharma GmbH | Ibuprofen-Brausezubereitung mit hoher Lösungsgeschwindigkeit und Verfahren zu deren Herstellung |
FR2909877B1 (fr) * | 2006-12-13 | 2009-07-10 | Galenix Dev Soc Par Actions Si | Composition pharmaceutique contenat de la 5-chloro-1-[1-[3- (2-oxo-2,3-dihydro-1h-benzimidazol-1-yl)propyl] piperidin-4-yl]-1,3-dihydro-2h-benzimidazol-2-one et son procede de preparation |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2292M (fr) | 1962-06-27 | 1964-01-27 | Sandoz Sa | Médicament a base d'une combinaison de dihydro-ergotamine, de caféine et d'une hydantoine. |
US4985459A (en) | 1984-02-08 | 1991-01-15 | Richardson-Vicks, Inc. | Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same |
EP0327040A3 (de) | 1988-02-05 | 1990-11-28 | Predrag Dr.Sc. Sikiric | Verwendung von Dopamin und/oder von Dopamin-Agonisten zur Herstellung eines Arzneimittels für die Behandlung des Verdauungstrakts |
US5053429A (en) | 1988-04-08 | 1991-10-01 | The Lithox Corporation, Inc. | Treating inflammatory pain with methionine |
GB8816187D0 (en) | 1988-07-07 | 1988-08-10 | Glaxo Group Ltd | Medicaments |
CA2020018A1 (en) | 1990-06-27 | 1991-12-28 | Don L. Simmons | Method and composition for treating the migraine complex |
US5215758A (en) | 1991-09-11 | 1993-06-01 | Euroceltique, S.A. | Controlled release matrix suppository for pharmaceuticals |
MX9300110A (es) | 1992-01-13 | 1994-07-29 | Gerhard Gergely | Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion. |
IT1264020B (it) | 1993-01-28 | 1996-09-09 | Recordati Chem Pharm | Procedimento per la preparazione di microgranuli idonei alla sospensione in liquidi |
TW466119B (en) | 1994-02-28 | 2001-12-01 | Janssen Pharmaceutica Nv | Film coated tablet of paracetamol and domperidone |
GB2313309B (en) * | 1996-05-24 | 2000-01-26 | Ninh Thuy On | Pharmaceutical compositions comprising a nonsteroidal anti-inflammatory drug and domperidone in the treatment of migraine |
GB9710767D0 (en) * | 1996-06-26 | 1997-07-23 | On Ninh | Analgesic and anti-inflamatory compositions comprising domperidone and methods of using same |
US5891885A (en) | 1996-10-09 | 1999-04-06 | Algos Pharmaceutical Corporation | Method for treating migraine |
GB9702392D0 (en) * | 1997-02-06 | 1997-03-26 | Boots Co Plc | Therapeutic agents |
GB9810092D0 (en) | 1998-05-11 | 1998-07-08 | Merck Sharp & Dohme | Therapeutic agents |
GB9816899D0 (en) * | 1998-08-05 | 1998-09-30 | Boots Co Plc | Therapeutic agents |
GB9822333D0 (en) | 1998-10-13 | 1998-12-09 | Merck Sharp & Dohme | Pharmaceutical formulation |
-
1998
- 1998-08-05 GB GBGB9816899.0A patent/GB9816899D0/en not_active Ceased
-
1999
- 1999-08-04 CN CN99811670A patent/CN1321084A/zh active Pending
- 1999-08-04 HU HU0103421A patent/HUP0103421A3/hu unknown
- 1999-08-04 CA CA002339193A patent/CA2339193C/en not_active Expired - Fee Related
- 1999-08-04 DE DE69906982T patent/DE69906982T2/de not_active Expired - Lifetime
- 1999-08-04 SK SK175-2001A patent/SK1752001A3/sk unknown
- 1999-08-04 AU AU61904/99A patent/AU755835B2/en not_active Ceased
- 1999-08-04 WO PCT/EP1999/005753 patent/WO2000007570A1/en not_active Application Discontinuation
- 1999-08-04 TR TR2001/00611T patent/TR200100611T2/xx unknown
- 1999-08-04 AT AT99948741T patent/ATE237316T1/de not_active IP Right Cessation
- 1999-08-04 BR BR9912706-7A patent/BR9912706A/pt not_active IP Right Cessation
- 1999-08-04 JP JP2000563256A patent/JP2002522377A/ja active Pending
- 1999-08-04 IL IL14105599A patent/IL141055A0/xx unknown
- 1999-08-04 PL PL99345811A patent/PL345811A1/xx not_active Application Discontinuation
- 1999-08-04 US US09/774,171 patent/US6991806B1/en not_active Expired - Fee Related
- 1999-08-04 KR KR1020017001539A patent/KR20010072269A/ko not_active Application Discontinuation
- 1999-08-04 MX MXPA01001120A patent/MXPA01001120A/es unknown
- 1999-08-04 NZ NZ509806A patent/NZ509806A/xx unknown
- 1999-08-04 ES ES99948741T patent/ES2197676T3/es not_active Expired - Lifetime
- 1999-08-04 EP EP99948741A patent/EP1100472B1/de not_active Expired - Lifetime
-
2001
- 2001-01-31 NO NO20010537A patent/NO20010537L/no not_active Application Discontinuation
- 2001-02-02 ZA ZA200100936A patent/ZA200100936B/en unknown
- 2001-03-01 BG BG105303A patent/BG105303A/xx unknown
-
2005
- 2005-09-22 US US11/232,038 patent/US20060013872A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1100472B1 (de) | 2003-04-16 |
CN1321084A (zh) | 2001-11-07 |
ES2197676T3 (es) | 2004-01-01 |
AU755835B2 (en) | 2002-12-19 |
GB9816899D0 (en) | 1998-09-30 |
WO2000007570A1 (en) | 2000-02-17 |
AU6190499A (en) | 2000-02-28 |
HUP0103421A2 (hu) | 2002-02-28 |
TR200100611T2 (tr) | 2001-10-22 |
HUP0103421A3 (en) | 2003-01-28 |
DE69906982T2 (de) | 2004-03-04 |
BR9912706A (pt) | 2002-01-29 |
EP1100472A1 (de) | 2001-05-23 |
NO20010537D0 (no) | 2001-01-31 |
US20060013872A1 (en) | 2006-01-19 |
JP2002522377A (ja) | 2002-07-23 |
ZA200100936B (en) | 2003-07-02 |
IL141055A0 (en) | 2002-02-10 |
BG105303A (en) | 2001-11-30 |
CA2339193A1 (en) | 2000-02-17 |
CA2339193C (en) | 2009-01-20 |
PL345811A1 (en) | 2002-01-14 |
KR20010072269A (ko) | 2001-07-31 |
SK1752001A3 (en) | 2001-08-06 |
US6991806B1 (en) | 2006-01-31 |
NO20010537L (no) | 2001-03-14 |
MXPA01001120A (es) | 2002-04-24 |
DE69906982D1 (de) | 2003-05-22 |
NZ509806A (en) | 2003-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG105568A (en) | Pharmaceutical compositions for modified release of an insulin sensitiser and another antidiabetic agent | |
TWI235068B (en) | Sustained-release pharmaceutical composition | |
GEP20022709B (en) | Pharmaceutical Compositions Having Appetite Suppressant Activity | |
ATE324907T1 (de) | Verbindung und arzneizusammensetzung zur verabreichung von wirkstoffen | |
ATE312080T1 (de) | 2-chinolonen enthaltende arzneimittel | |
GEP20022851B (en) | Flash-Melt Oral Dosage Formulation | |
MX9204268A (es) | Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma. | |
DE69434626D1 (de) | Transparente flüssigkeit zur verabreichung von verkapselten medikamenten | |
DE69906982D1 (de) | Ibuprofen und domperidone enthaltende pharmazeutische zusammensetzungen | |
TR200000517T2 (tr) | Piperidinoalkanol-Konjesyon azaltıcıdan oluşan kombinasyona yönelik farmasötik kompozisyon. | |
BR0108478A (pt) | Formulação nutritiva contendo substancias pré-bióticas | |
DE69901487D1 (de) | Eine didemnin verbindung enthaltende pharmazeutische formulierung | |
AU5158699A (en) | Fast dissolving ibuprofen containing compositions having analgesic activity | |
GEP20033118B (en) | Meta-Azacyclic Amino Benzoic Acid Compounds and Derivatives Thereof Being Integrin Inhibitors, Pharmaceutical Composition and Use Thereof | |
BG104916A (en) | Calcilytic compounds | |
BG105570A (en) | Pharmaceutical compositions for modified release insulin sensitiser | |
NO943374L (no) | Psylliumholdig materialsammensetning | |
EA200100253A1 (ru) | Микронизированные фармацевтические композиции | |
DE69416034D1 (de) | Pharmazeutische Zubereitung zur rektalen Verabreichung von pharmakologisch wirksamen Verbindungen | |
EA200400954A1 (ru) | Фармацевтическая композиция, содержащая 2,2-дихлор-12-(4-хлорфенил)додекановую кислоту | |
AP1692A (en) | Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent. | |
JO1519B1 (en) | New compounds (new benzimidazole derivatives are effective as ulcers) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |